Target intelligence / Profile preview

Macrophage-mediated extracellular matrix remodeling and myofibroblast activation pathway

Molecular classification
Biological pathway, Cell signaling network
01

Overview

The macrophage-mediated extracellular matrix (ECM) remodeling and myofibroblast activation pathway is a critical signaling axis involved in tissue repair and the pathogenesis of chronic fibrosis (Wynn & Barron, 2010, Nature). In response to injury, M2-polarized macrophages secrete pro-fibrotic cytokines such as Transforming Growth Factor-beta 1 (TGF-beta1) and Platelet-Derived Growth Factor (PDGF) (Buechler et al., 2021, Nature Communications). These macrophages also release Matrix Metalloproteinases (MMPs) that degrade the basement membrane and ECM, facilitating the migration of fibroblasts and the release of bound growth factors (Giannandrea & Parks, 2014, Reviews in Physiology, Biochemistry and Pharmacology). The resulting signaling environment triggers the differentiation of resident fibroblasts into contractile myofibroblasts, a process marked by the expression of alpha-smooth muscle actin (alpha-SMA) (Meng et al., 2016, Nature Reviews Nephrology). Myofibroblasts are the primary effectors of fibrosis, producing excessive amounts of collagen and other matrix proteins that lead to organ scarring and functional impairment. This pathway is a major driver of diseases such as idiopathic pulmonary fibrosis, liver cirrhosis, and systemic sclerosis. Therapeutic strategies targeting this pathway include the use of tyrosine kinase inhibitors like Nintedanib and TGF-beta synthesis inhibitors like Pirfenidone (Richeldi et al., 2014, NEJM). Emerging treatments also focus on modulating macrophage polarization or inhibiting specific MMPs to restore homeostatic ECM turnover.

Other names
Macrophage-myofibroblast transition (MMT) pathwayPro-fibrotic macrophage-fibroblast axisMacrophage-driven fibrotic signalingM2 macrophage-mediated myofibroblast activation
02

Mechanism of action

Inhibition of TGF-beta signaling, blockade of tyrosine kinase receptors (PDGFR, FGFR, VEGFR), and modulation of macrophage polarization to prevent myofibroblast differentiation and excessive ECM deposition.

03

Biological functions

Extracellular matrix remodelingFibroblast activationWound healingImmune responseTissue repair
04

Disease associations

FibrosisCancerChronic inflammationCardiovascular disease
05

Safety considerations

Impaired wound healingGastrointestinal toxicityHepatotoxicityPotential for systemic immunosuppression
06

Interacting drugs

Nintedanib

4 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (alpha-SMA)Transforming growth factor-beta 1 (TGF-beta1)Matrix metalloproteinase-9 (MMP-9)Pro-collagen type III N-terminal peptide (PIIINP)

Beyond the preview

Go deeper on Macrophage-mediated extracellular matrix remodeling and myofibroblast activation pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage-mediated extracellular matrix remodeling and myofibroblast activation pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call